Gefitinib Tablets 250 mg

Committed to serve the customers in an ethical and transparent manner, we are highly preferred in market for manufacturing and exporting a quality range of Gefitinib Tablets. In medical institutions and hospitals, these tablets are highly used to treat non-small cell lung cancer. For formulation of the tablets, we use finest quality compounds, sourced from the most reliable and certified vendors. Our quality inspectors check the Gefitinib 250 mg Tablets on purity and effectiveness parameters to offer a flawless range to the clients.

Features:

• Highly effective

• Zero adverse effects

• Accurately composed and formulated
  

Gefitinib Tablets 250 mg

Indications:

Advanced or metastatic Non Small Cell Lung Cancer (NSCLC)
       
Dosage :
ADULT : 250 mg tablet once a day, taken with or without food.

Dosage Adjustment :

Renal Impairment : Not Required in mild to moderate renal impairment.

Hepatic Impairment : Administer with caution.
      
Packing:    3 Strips of 10 Tablets

We also deals in: